Stem cells and cell therapy approaches in lung biology and diseases

Por Sueblinvong, Viranuj, Weiss, Daniel J.
Publicado em 2010

Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA(2)α in phorbol ester-treated non-small cell lung cancer A549 cells

Por Tsou, Jen-Hui, Chang, Kwang-Yu, Wang, Wei-Chiao, Tseng, Joseph T., Su, Wu-Chou, Hung, Liang-Yi, Chang, Wen-Chang, Chen, Ben-Kuen
Publicado em 2008

Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells

Por Gurunathan, Sangiliyandi, Jeong, Jae-Kyo, Han, Jae Woong, Zhang, Xi-Feng, Park, Jung Hyun, Kim, Jin-Hoi
Publicado no Nanoscale Res Lett (2015)

Epidermal growth factor tyrosine kinase inhibitor therapy inferior to second-line chemotherapy in EGFR wild-type non-small cell lung cancer patients: results of French nationwide observational study

Por Lisberg, Aaron, Garon, Edward B.
Publicado no Transl Lung Cancer Res (2017)

Do EGFR tyrosine kinase inhibitors (TKIs) still have a role in EGFR wild-type pre-treated advanced non-small cell lung cancer (NSCLC)?—the shifting paradigm of therapeutics

Por Itchins, Malinda, Clarke, Stephen, Pavlakis, Nick
Publicado no Transl Lung Cancer Res (2018)

Systemic Blockade of Transforming Growth Factor-β (TGF-β) Signaling Augments the Efficacy of Immunogene Therapy

Por Kim, Samuel, Buchlis, George, Fridlender, Zvi G., Sun, Jing, Kapoor, Veena, Cheng, Guanjun, Haas, Andrew, Cheung, Hung Kam, Zhang, Xiamei, Corbley, Michael, Kaiser, Larry R., Ling, Leona, Albelda, Steven M.
Publicado em 2008

Targets of Transcriptional Regulation by Transforming Growth Factor‐β: Expression Profile Analysis Using Oligonucleotide Arrays

Por Akiyoshi, Shingo, Ishii, Masami, Nemoto, Nobuo, Kawabata, Masahiro, Aburatani, Hiroyuki, Miyazono, Kohei
Publicado no Jpn J Cancer Res (2001)

Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond

Por Khoo, Christine, Rogers, Toni-Maree, Fellowes, Andrew, Bell, Anthony, Fox, Stephen
Publicado no Transl Lung Cancer Res (2015)

Transforming growth factor-β receptor 2 gene polymorphisms are associated with end-stage renal disease

Por Ki, Hye-Jin, Kim, Se Yun, Lee, Sang Ho, Moon, Ju-Young, Jeong, Kyung Hwan, Lee, Tae Won, Ihm, Chun Gyoo, Kim, Su Kang, Chung, Joo-Ho, Kang, Sun Woo, Kim, Tae Hee, Kim, Yeong-Hoon, Kim, Yang Gyun
Publicado no Kidney Res Clin Pract (2015)

Activated RET and ROS: two new driver mutations in lung adenocarcinoma

Por Bos, Marc, Gardizi, Masyar, Schildhaus, Hans-Ulrich, Buettner, Reinhard, Wolf, Juergen
Publicado no Transl Lung Cancer Res (2013)

O13. Subtype-specific KRAS mutations in advanced lung adenocarcinoma

Por Lohinai, Zoltan, Cserepes, Mihaly, Ostoros, Gyula, Moldvay, Judit, Ghanim, Bahil, Laszlo, Viktoria, Hoda, Mir Alireza, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Publicado no Transl Lung Cancer Res (2014)

P26. Well differentiated neuroendocrine tumors of the lung—our experience

Por Kulísková, Jana, Fischer, Ondrej, Kultan, Juraj, Polášek, Vladan, Grygárková, Ivona, Kolek, Vitezslav, Tichý, Tomáš
Publicado no Transl Lung Cancer Res (2014)

In vivo tumorigenesis by Jaagsiekte sheep retrovirus (JSRV) requires Y590 in Env TM, but not full length orfX open reading frame

Por Cousens, Chris, Maeda, Naoyoshi, Murgia, Claudio, Dagleish, Mark P., Palmarini, Massimo, Fan, Hung
Publicado em 2007

BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung

Por Martinez, Jarrod, Zhang, Xiang H-F
Publicado em 2013

Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?

Por Tzouvelekis, Argyris, Anevlavis, Stavros, Bouros, Demosthenes
Publicado em 2006

RASSF1A deficiency enhances RAS driven lung tumorigenesis

Por Schmidt, M. Lee, Hobbing, Katharine R., Donninger, Howard, Clark, Geoffrey J.
Publicado no Cancer Res (2018)

Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis

Por Novitskiy, Sergey V, Forrester, Elizabeth, Pickup, Michael W, Gorska, Agnieszka E, Chytil, Anna, Aakre, Mary, Polosukhina, Dina, Owens, Philip, Yusupova, Dilyara R, Zhao, Zhiguo, Ye, Fei, Shyr, Yu, Moses, Harold L
Publicado no Breast Cancer Res (2014)

FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications

Por Schildhaus, Hans-Ulrich, Nogova, Lucia, Wolf, Jürgen, Buettner, Reinhard
Publicado no Transl Lung Cancer Res (2013)

Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation

Por Leslie, Kenneth, Gao, Sizhi P, Berishaj, Marjan, Podsypanina, Katrina, Ho, Hao, Ivashkiv, Lionel, Bromberg, Jacqueline
Publicado em 2010

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harboring EGFR mutations (JO25567): an open-label, randomized, multicenter...

Por Yoshida, Kazushi, Yamada, Yasuhide
Publicado no Transl Lung Cancer Res (2015)